LEDOUX MEDICAL
ActiveSummary
LEDOUX MEDICAL has been active since 2009 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.21M and a net result of €259k. Equity is growing by ~15.7% per year across the filed fiscal years. Its solvency ranks better than 76% of 16546 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
87
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability91▼-4
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €100k at 30 days acceptable
Liquidity ample (current ratio 6.11 against 6.43 in 2024; short-term debt: 15% and cash: 3.6% of total assets), and 15% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
85%
Return on assets
18.2%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
31 d late
2024
29 d late
2023
29 d late
2022
37 d late
2021
26 d early
2020
31 d late
2019
90 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€1.21M▲ 10.2%
2024 · €1.10M
2018: €638k
2019: €504k
2020: €644k
2021: €654k
2022: €777k
2023: €940k
2024: €1.10M
2018 → 2025
Total assets
€1.42M▲ 10.6%
2024 · €1.29M
2018: €685k
2019: €554k
2020: €701k
2021: €771k
2022: €915k
2023: €1.10M
2024: €1.29M
2018 → 2025
Net result
€259k▼ 5.4%
2024 · €273k
2018: €92k
2019: €118k
2020: €147k
2021: €222k
2022: €198k
2023: €255k
2024: €273k
2018 → 2025
Working capital
€1.09M▲ 5.9%
2024 · €1.03M
2018: €560k
2019: €433k
2020: €584k
2021: €606k
2022: €729k
2023: €891k
2024: €1.03M
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€654k-€777k▲ 18.9%€940k▲ 21.0%€1.10M▲ 16.5%€1.21M▲ 10.2%
Operating result€340k-€316k▼ 7.0%€365k▲ 15.6%€382k▲ 4.7%€392k▲ 2.6%
Net result€222k-€198k▼ 10.8%€255k▲ 28.8%€273k▲ 7.1%€259k▼ 5.4%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2022 the operating result has climbed three years in a row; 2025 is 3% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.42M
Fixed assets
€116k ▲ 78.7%
Current assets
€1.30M ▲ 6.9%
Equity and liabilities €1.42M
Equity
€1.21M ▲ 10.2%
Debt
€213k ▲ 12.5%
Debt's share of the balance-sheet total rises from 14.8% to 15.0%. Equity and debt are higher.
Key figures and ratios
EBITDA
€406k▲
2024 · €394k
Cash flow
€273k▼
2024 · €285k
Current ratio
6.11▼
2024 · 6.43
Debt to equity
0.18▲
2024 · 0.17
ROE
21.4%▼
2024 · 25.0%
ROA
18.2%▼
2024 · 21.3%
Interest coverage
16.90▼
2024 · 64.76
Debt ≤ 1 year
€213k▲
2024 · €190k
Income taxes
€131k▲
2024 · €125k
Staff costs
€38k▼
2024 · €39k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 45 lines
Balance sheet
Code20242025
Assets
Total assets20/58€1.29M€1.42M▲
Fixed assets21/28€65k€116k▲
Tangible fixed assets22/27€65k€116k▲
Land and buildings22€59k€112k▲
Plant, machinery and equipment23-€3k
Furniture and vehicles24€5k€768▼
Financial fixed assets28€240€240=
Current assets29/58€1.22M€1.30M▲
Amounts receivable within one year40/41€1k€14k▲
Trade receivables40€1k€14k▲
Current investments50/53€1.12M€1.24M▲
Cash at bank and in hand54/58€94k€52k▼
Deferred charges and accrued income490/1€2k€2k▼
Equity and liabilities
Total equity and liabilities10/49€1.29M€1.42M▲
Equity10/15€1.10M€1.21M▲
Reserves13€1.10M€1.21M▲
Distributable reserves133€1.10M€1.21M▲
Amounts payable17/49€190k€213k▲
Amounts payable within one year42/48€190k€213k▲
Current portion of amounts payable after more than one year42€34k€34k▲
Trade debts44€3k€5k▲
Suppliers440/4€3k€5k▲
Taxes, remuneration and social security45€36k€31k▼
Taxes450/3€30k€25k▼
Remuneration and social security454/9€6k€5k▼
Other amounts payable47/48€116k€144k▲
Income statement
Code20242025
Remuneration, social security and pensions62€39k€38k▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€12k€14k▲
Other operating charges640/8€3k€2k▼
Gross operating margin9900€435k€446k▲
Operating profit (loss)9901€382k€392k▲
Financial income75/76B€23k€22k▼
Recurring financial income75€23k€22k▼
Financial charges65/66B€6k€24k▲
Recurring financial charges65€6k€24k▲
Profit (loss) for the period before taxes9903€399k€390k▼
Income taxes67/77€125k€131k▲
Profit (loss) for the period9904€273k€259k▼
Profit (loss) for the period to be appropriated9905€273k€259k▼
Appropriation of the result
Profit (loss) to be appropriated9906€273k€259k▼
Transfer from equity791/2€118k€147k▲
Transfer to equity691/2€273k€259k▼
To other reserves6921€273k€259k▼
Profit to be distributed694/7€118k€147k▲
Return on contributions (dividend)694€118k€147k▲
The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
31-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 31 days late
2025
29-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 29 days late
2024
31-12
Financial
Highest result since 2018net €273k ▲7.1%
Net result €273k, the highest in the series.
31-12
Financial
Equity above €1MEq €1.10M ▲16.5%
7 profitable years in a row build equity to €1.10M.
29-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 29 days late
2023
06-09
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 37 days late
2022
05-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
31-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 31 days late
2020
29-10
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 90 days late
2019
16-07
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
30-08
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 30 days late
2017
29-08
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema · 29 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
5 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Charleroi · 1 establishment unit since 2010
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Chaussée de Bruxelles 346042 CharleroiGround area
1,020 m²
Building footprint
122 m²
Volume, LiDAR
1,078 m³
Parcel 52040C0098/00M005, Wallonia · tallest building 11.5 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
Chaussée de Bruxelles 34, 6042 Charleroi
since 20102.183.995.382
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 52040C0098/00M005 | Wallonia | 1,020 m² | 1 · 122 m² | 11.5 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
984500E6B9CBBD0A5116
Similar companies · same sector, comparable size
Emmetropia
BE 0782.345.877
Heusden-Zolder · Eq €1,207,709
DR. D. JAMAER
BE 0479.315.701
Hasselt · Eq €1,208,135
VERE
BE 0430.067.217
Genk · Eq €1,205,615
ANESTESIST - URGENTIEARTS DR. GILLIS MARC
BE 0463.656.634
Heist-op-den-Berg · Eq €1,205,535
Dr. VANDE VIJVER GEERT
BE 0865.117.561
Sint-Niklaas · Eq €1,209,249
Of 16,627 companies in sector 86220 we hold annual accounts for 7,974. 5,508 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded01-09-2009
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
86995Nutrition and dietetics services
Sources
Crossroads Bank for EnterprisesNational Bank · 15 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.